Purpose: To quantify decreases in health-related quality of life (HRQoL) for given deterioration in clinical measures of vision; to describe the shape of these relationships; and to test whether the gradients of these relationships change with duration of visual loss.
ASJC Scopus subject areas
Reeves, J., Langham, J., Walker, L., Grieve, J., Chakravarthy, U., Tomlin, K., Carpenter, J., Guerriero, C., & Harding, M. (2009). Verteporfin Photodynamic Therapy Cohort Study Report 2: Clinical Measures of Vision and Health-Related Quality of Life. Ophthalmology, 116(12), 2463-2470. https://doi.org/10.1016/j.ophtha.2009.10.031